<abstract xmlns="http://www.w3.org/1999/xhtml"><p>Hodgkin lymphoma, formerly known as Hodgkin disease, has gone from an incurable disease to one with a cure rate of almost 75%. The disease is defined in terms of its microscopic appearance (histology) and the expression of cell surface markers (immunophenotype), but its biologic behavior and clinical characteristics are also important.</p><p>Treatment of Hodgkin lymphoma is tailored to disease type, disease stage, and an assessment of the risk of resistant disease. General treatment modalities include radiation therapy, induction chemotherapy, salvage chemotherapy, and hematopoietic stem cell transplantation.</p></abstract>

Hodgkin lymphoma, formerly known as Hodgkin disease, has gone from an incurable disease to one with a cure rate of almost 75%. The disease is defined in terms of its microscopic appearance (histology) and the expression of cell surface markers (immunophenotype), but its biologic behavior and clinical characteristics are also important.Treatment of Hodgkin lymphoma is tailored to disease type, disease stage, and an assessment of the risk of resistant disease. General treatment modalities include radiation therapy, induction chemotherapy, salvage chemotherapy, and hematopoietic stem cell transplantation.

Present and Future in Treatment of Hodgkin Lymphoma

“Carol Davila” University of Medicine and Pharmacy

Internal Medicine

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

{"article-title":"Present and Future in Treatment of Hodgkin Lymphoma"}

Hodgkin lymphoma, formerly known as Hodgkin disease, has gone from an incurable disease to one with a cure rate of almost 75%. The disease is defined in terms...

Present and Future in Treatment of Hodgkin Lymphoma

Published Online: Jun 06, 2019

Page range: 33 - 39

DOI: https://doi.org/10.2478/inmed-2019-0050

Keywords
Hodgkin lymphoma, histology, immunophenotype, Hodgkin-Reed-Sternberg cell, chemotherapy

© 2019 Andrei Turbatu et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Present and Future in Treatment of Hodgkin Lymphoma

Published Online: Jun 06, 2019

Page range: 33 - 39

DOI: https://doi.org/10.2478/inmed-2019-0050

KeywordsHodgkin lymphoma, histology, immunophenotype, Hodgkin-Reed-Sternberg cell, chemotherapy

© 2019 Andrei Turbatu et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Keywords
Hodgkin lymphoma, histology, immunophenotype, Hodgkin-Reed-Sternberg cell, chemotherapy